https://www.pepcodex.com/peptides/ecnoglutide
Ecnoglutide: 10 Studies Reviewed (2026) | PepCodex
Evidence-graded review of ecnoglutide (XW003). Long-acting GLP-1 agonist with 13.2% weight loss in a Phase 3 obesity trial. Updated Apr 2026.
ecnoglutidestudiesreviewed